Clinical Trials on Pharmacogenetic Testing

Total 2383 results

RWTH Aachen University
B. Braun-Stiftung

Not yet recruiting

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

Drug-Related Side Effects and Adverse Reactions | Pharmacogenetics | Polypharmacy | Pharmacogenomic Testing
Centre Hospitalier Universitaire Vaudois

Not yet recruiting

Pharmacogenetic Testing at Community Pharmacy (OffiGene)

Pharmacogenetic Testing
University of Florida
National Center for Advancing Translational Sciences (NCATS)

Completed

Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients

Pharmacogenetic Testing

United States
Duke University
National Institute of General Medical Sciences (NIGMS)

Completed

Pharmacogenetic Testing in Primary Care

Pharmacogenetic Testing

United States
University of Florida
National Human Genome Research Institute (NHGRI)

Recruiting

Trial of Preemptive Pharmacogenetics in Underserved Patients (ToPP-UP)

Pharmacogenetic Testing | Use of Prescription Medications

United States
Seattle Institute for Biomedical and Clinical Research
Genomind, LLC

Completed

Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population (MedOPT)

Pharmacogenetic Testing

United States
Geisinger Clinic

Enrolling by invitation

Preemptive Pharmacogenomics Testing Among Geriatric Patients

Polypharmacy | Pharmacogenomic Testing

United States
Lawson Health Research Institute

Not yet recruiting

Personalized Pharmacotherapy Using Pharmacogenetics in Veterans (PGx)

Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD
Vanderbilt University Medical Center

Recruiting

VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey (MPRINT)

Pharmacogenomic Testing

United States
ClinLogic LLC

Recruiting

Reduction of Adverse Drug Events and Readmissions (RADAR-PGX)

Pharmacogenomic Testing for Medication Management

United States
Tabula Rasa HealthCare

Enrolling by invitation

Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly

Pain | Pain, Acute | Elderly | Opioid Use | Pain, Chronic | Pharmacogenetic Testing

United States
USDA, Western Human Nutrition Research Center
University of California, Davis

Completed

Time Restricted Feeding in Male Runners

Cardiovascular Risk Factor | Athletic Performance | Fasting | Resting Energy Expenditure | Intermittent Fasting

United States
Duke University
National Institute of General Medical Sciences (NIGMS)

Completed

Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting

Pharmacogenetics

United States
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomédica; Fundació Institut de Recerca de... and other collaborators

Unknown

Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers (APSEP)

Healthy | Pharmacogenetics

Spain
Awenydd GmbH

Unknown

Medication Optimisation for Reducing Events in a Private Practice Setting (MORE)

Pharmacogenetic Analysis to Reduce Events.

Germany
University of Washington
Oregon Health and Science University; National Institute of General Medical...

Unknown

Naproxen Pharmacogenetic Study (Project 1, Aim 2)

Pharmacogenetics

United States
University of British Columbia
GlaxoSmithKline; Merck Sharp & Dohme LLC; Pfizer; Roche Pharma AG; AstraZeneca; Janssen... and other collaborators

Completed

The Implementation of Pharmacogenomics Into Primary Care in British Columbia (IPPC)

Pharmacogenetics
Chonnam National University Hospital
Institute of Bioequivalence and Bridging Study, College of Pharmacy, CNU

Completed

Bioequivalence of Rebamipide in Korean

Pharmacogenetics | Therapeutic Equivalency

Korea, Republic of
IRCCS Burlo Garofolo

Recruiting

Pharmacogenetics Analysis of Fentanyl Administered in Newborns

Pharmacogenetics | Newborn | Fentanyl

Italy
Duke University

Completed

Medication Therapy Management With Pharmacogenetic Testing

Pharmacogenetics | Medication Therapy Management

United States
University Children's Hospital, Zurich

Terminated

Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants

Pharmacokinetic

Switzerland
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants.

Pharmacokinetic

China
IDEA AG

Completed

Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

Pharmacokinetic

Germany
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects

Pharmacokinetic

China
Gesynta Pharma AB
CTC Clinical Trial Consultants AB; RISE Research Institutes of Sweden AB

Completed

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

Pharmacokinetic

Sweden
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects

Pharmacokinetic
Beijing Continent Pharmaceutical Co, Ltd.

Completed

F573 Ia Clinical Trial

Tolerance | Pharmacokinetic

China
Lupin Ltd.

Completed

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

Pharmacokinetic Study

India
AstraZeneca

Completed

Assessment of the Effect of Food on ABT-143 Bioavailability

Pharmacokinetic Variables

United States
Norgine
Quotient Sciences

Completed

A Pharmacokinetic Study of PLENVU® in Healthy Subjects (PKPU)

Pharmacokinetic

United Kingdom
Inversago Pharma Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects

Pharmacokinetic

Canada
Bausch Health Americas, Inc.

Completed

Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers

Pharmacokinetic
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

Pharmacokinetic

Belgium
Grünenthal GmbH

Completed

Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of Charcoal

Pharmacokinetic

Germany
Data Collection Analysis Business Management
PAS Research Services

Unknown

Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

Pharmacogenomic

United States
University of Oxford
Mahidol Oxford Tropical Medicine Research Unit; Faculty of Tropical Medicine...

Withdrawn

A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body (PQcPQ)

Healthy | Pharmacokinetic

Thailand
AnHeart Therapeutics Inc.

Completed

Study the Effect of Omeprazole on AB-106 Pharmacokinetics

Pharmacokinetic Study

China
Mutah University

Completed

Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting and Fed Conditions

Pharmacokinetic Parameters

Jordan
Xention Ltd

Completed

A Preliminary Drug Drug Interaction Study With TA-8995

Pharmacokinetic Interactions

United Kingdom
University Hospital, Limoges

Completed

Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation (IMPAKT)

Transplantation | Pharmacokinetic | Kidney

France
Pharmaceutical Productions Inc.
National Institute on Drug Abuse (NIDA)

Completed

Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge

Nicotine Pharmacokinetic Study

United States
Ain Shams University

Completed

Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

Pharmacokinetics | Pharmacogenomic

Egypt
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

Pharmacokinetic Study

China
Poitiers University Hospital

Unknown

Toxicokinetic Study of Dichlorobisphenol A After an Oral or Dermal Single Dose in Healthy Volunteer. (PRECEPT)

Pharmacokinetic Study

France
Gedeon Richter Plc.

Completed

Cariprazine: Comparison of Slow- and Immediate-release Forms

Pharmacokinetic Profile

United Kingdom
Chinese Academy of Sciences
LanZhou University

Completed

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

Pharmacokinetic | Genotype

China
Medibiofarma S.L.

Completed

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Safety and Pharmacokinetic

Spain
Fraunhofer-Institute of Toxicology and Experimental...
AstraZeneca

Completed

Use of Exhaled Particles to Assess Lung Pharmacokinetics (EXPLORE)

Healthy | Lung Pharmacokinetic

Germany
Western University, Canada

Unknown

Effect of Eating Timing on Body Composition

Fasting | Time-Restricted Eating (16:8)

Canada
AstraZeneca

Completed

Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK

Healthy Volunteers Pharmacokinetic Study

United Kingdom

Clinical Trials on Pharmacogenetic Testing

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations